National Institute of Mental Health (NIMH): all 367 studies

Page 2 of 4. Open to participants first (45), then studies with results posted, then the rest; newest registration first within each.

• Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual ResponsesCompletedNCT04377100
• Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and VolunteersCompletedNCT04339790
• Ask Suicide-Screening Questions (ASQ) for Youth With Autism Spectrum and Neurodevelopmental DisordersCompletedNCT04317118
• Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)WithdrawnNCT03895658Phase 1
• Evaluation of a Novel PET Radioligand to Image OGACompletedNCT03632226
• Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)TerminatedNCT03507218
• Development of Non-Invasive Brain Stimulation TechniquesCompletedNCT03351764Not applicable
• Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)CompletedNCT03324646
• Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive EpisodesCompletedNCT03289923Not applicable
• Procedures for Sample Acquisition and Distribution for The Human Brain Collection CoreTerminatedNCT03092687
• Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B)TerminatedNCT03030391Phase 1
• Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient SettingsTerminatedNCT02830334
• Spatial Context and Fear LearningCompletedNCT02423044
• Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial DistressCompletedNCT02423031
• Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)CompletedNCT02363296Not applicable
• Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral DisorderWithdrawnNCT02247986Phase 1/2
• PET Imaging of Brain mGluR1 Receptors Using [18F]FIMXCompletedNCT02230592
• PET Imaging in Chronic Traumatic EncephalopathyCompletedNCT02211820
• Specific PET Radioligand Binding to Translocator ProteinCompletedNCT02181582Phase 1
• Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy PeopleCompletedNCT02147392Early Phase 1
• Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical InpatientsCompletedNCT02140177
• Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8TerminatedNCT02108015Phase 1
• Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical SettingTerminatedNCT02050867
• Imaging and Genetic Investigation of Learning and Decision MakingCompletedNCT01950377
• Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in BrainCompletedNCT01896843Phase 1
• Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct DisordersTerminatedNCT01867398
• Brain Inflammation in Major Depressive Disorder BackgroundCompletedNCT01851356
• Study of [11C]DPA-713 for Temporal Lobe EpilepsyCompletedNCT01793532
• Studying Childhood-onset Behavioral, Psychiatric, and Developmental DisordersCompletedNCT01778504
• A Pilot Study to Extend the K-SADS-PL to Adolescents and Young AdultsCompletedNCT01778478
• Near Infrared Spectroscopy in Children With Autism and ADHDTerminatedNCT01730079
• Daily Intranasal Oxytocin for Childhood-Onset SchizophreniaTerminatedNCT01712646Phase 1/2
• Brain Imaging, Genetics and Treatment for Major DepressionWithdrawnNCT01568684Phase 1
• Mild Neurocognitive Disorder in HIV Infection of the BrainTerminatedNCT01547754
• Assessing Suicide Risk in Adolescents With Developmental DelaysTerminatedNCT01517126
• Imaging of Brain Receptors Using (11C)mGlu1TerminatedNCT01420952Phase 1
• Imaging of CB1 Receptors Using (11C)SD5024TerminatedNCT01399398Phase 1
• (18F)FCWAY and the Blood-Brain BarrierCompletedNCT01386476
• Study of Toddlers With Language DelayCompletedNCT01339767
• Oxytocin and Arginine Vasopressin in Pain ReliefTerminatedNCT01328561
• A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
• Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderWithdrawnNCT01313403Not applicable
• An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United StatesCompletedNCT01211990
• PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1ACompletedNCT01198197Early Phase 1
• A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
• PET Whole Body Distribution Studies Using [11C]CUMICompletedNCT01132872
• Brain Imaging Study of Adults With Autism Spectrum DisordersCompletedNCT01093768Phase 1
• Imaging Cannabinoid CB1 Receptors in SchizophreniaTerminatedNCT01063335
• Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female VolunteersCompletedNCT01059227
• Cognitive Neuroscience of Autism Spectrum DisordersCompletedNCT01031407
• A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive DisorderTerminatedNCT01019967
• Characterizing Lone Parenting: A Multi-institutional Pilot Study of the Perceptions of Support and Perceived Stress of Lone Parents of Children With CancerCompletedNCT00969579
• Depression Outcomes Study of ExerciseCompletedNCT00964054Phase 1
• Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's DiseaseCompletedNCT00955422
• Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission TomographyCompletedNCT00942981
• Identification of Characteristics Associated With Symptom Remission in AutismCompletedNCT00938054
• CO2 Inhalation and Risk for Panic DisorderTerminatedNCT00930657
• Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical NetworkCompletedNCT00930150Phase 4
• Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory ConsolidationCompletedNCT00884702
• Development and Decline of Brain and Cognition Through the Life SpanCompletedNCT00880451
• The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot StudyCompletedNCT00824278
• Imaging Cannabinoid CB1 Receptors in Alcohol DependenceCompletedNCT00816439
• Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset SchizophreniaTerminatedNCT00757497Phase 1
• Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum PeriodWithdrawnNCT00720395
• p11 Protein Levels in Patients With Major Depressive Disorder Treated With CitalopramCompletedNCT00697268
• PET Imaging of Peripheral Benzodiazepine ReceptorsCompletedNCT00696371
• P-glycoprotein Function in Brain DiseasesCompletedNCT00677885
• Mirror Therapy for Phantom Limb PainCompletedNCT00623818
• Detecting Risk of Suicide in a Pediatric Emergency DepartmentCompletedNCT00623493
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal DementiaCompletedNCT00613119
• PET Imaging of P-glycoprotein Function Using [11C]dLopCompletedNCT00605254
• PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEPCompletedNCT00598390Phase 1
• PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2CompletedNCT00598286Phase 1
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid AtherosclerosisCompletedNCT00547976Phase 1
• PET Imaging of Brain mGluR5 Receptors Using [18F]SP203CompletedNCT00538798Phase 1
• Assessing Treatment Emergent Suicidal Ideation in Patients With Major DepressionCompletedNCT00532103
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBCompletedNCT00527579Phase 1
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28CompletedNCT00526916Phase 1
• A Glutamate Transporter GLT1, in the Treatment of Bipolar DisorderWithdrawnNCT00512616Phase 2
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
• Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and MemoryCompletedNCT00458432
• Imaging of Cannabinoid Receptors Using New Radioactive TracerCompletedNCT00450021Phase 1
• PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28CompletedNCT00407693Phase 1
• PET Imaging of Brain Amyloid Using [11C]MeS-IMPYCompletedNCT00407576Phase 1
• PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00397748
• Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
• Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant MedicationCompletedNCT00375843Phase 4
• Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsCompletedNCT00369798Phase 1
• Protein Synthesis in the Brain of Patients With Fragile X SyndromeCompletedNCT00362843
• Effect of D-cycloserine on Extinction of Fear ConditioningCompletedNCT00352586
• Psychological Mechanisms of Behavioral DysregulationCompletedNCT00352456
• Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in MaliCompletedNCT00339391
• Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar DisorderWithdrawnNCT00327756Phase 2
• Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood DisordersCompletedNCT00325065
• Clinical and Immunological Investigations of Subtypes of AutismCompletedNCT00298246
• PET Imaging of Brain Peripheral Benzodiazepine ReceptorsCompletedNCT00283920Phase 1
• PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAYCompletedNCT00263523Phase 1
• PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]RolipramCompletedNCT00250172Phase 1
• Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in AdolescentsCompletedNCT00183690Phase 1
• Usability of a Website for People With SchizophreniaWithdrawnNCT00177879Not applicable

← National Institute of Mental Health (NIMH) overview and focus areas